The FDA on July 31, 2018 approved MULPLETA® for thrombocytopenia in adults with Chronic Liver Disease (CLD) who are scheduled to undergo a medical or dental procedure. MULPLETA® is a product of Shionogi Inc.
Bottom Ad
Advertisement
Subscribe
Top Ad
Advertisement